Acetyl-l-carnitine rescues scopolamine-induced memory deficits by restoring insulin-like growth factor II via decreasing p53 oxidation

Neuropharmacology

Volumn 76, Issue PART A, 2014, Pages 80-87

  Wang, Xiang ^a   Wang, Liang Ping ^a   Tang, Hui ^a   Shan, Wan Ying ^a   Wang, Xiong ^a   Liu, Dan ^a   Wu, Yuan Yuan ^a   Tian, Qing ^a   Wang, Jian Zhi ^a   Zhu, Ling Qiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acetyl l carnitine; IGF II; Oxidative stress; p53

Indexed keywords

CARNITINE; LEVACECARNINE; PROTEIN P53; SCOPOLAMINE; SOMATOMEDIN B; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITE; DRUG MECHANISM; ENZYME ACTIVITY; LEARNING DISORDER; LONG TERM POTENTIATION; MALE; METABOLIC REGULATION; NEUROLOGIC DISEASE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN TRANSPORT; RAT; SYNAPSE;

ACETYL-L-CARNITINE; IGF II; OXIDATIVE STRESS; P53;

ACETYLCARNITINE; ANIMALS; ANTIOXIDANTS; HIPPOCAMPUS; INSULIN-LIKE GROWTH FACTOR II; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; MEMORY DISORDERS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; SCOPOLAMINE HYDROBROMIDE; SUPEROXIDE DISMUTASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84886598792     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.08.022     Document Type: Article

References (70)

1. H.M. Abdul, V. Calabrese, M. Calvani, and D.A. Butterfield Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease J. Neurosci. Res. 84 2006 398 408 (Pubitemid 44126292)
2. T. Ahmed, and A.H. Gilani Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease Pharmacol. Biochem. Behav. 91 2009 554 559
3. B.N. Ames, M.K. Shigenaga, and T.M. Hagen Oxidants, antioxidants, and the degenerative diseases of aging Proc. Natl. Acad. Sci. U. S. A. 90 1993 7915 7922 (Pubitemid 23260825)
4. M.E. Bach, R.D. Hawkins, M. Osman, E.R. Kandel, and M. Mayford Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency Cell 81 1995 905 915
5. C.A. Barnes Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat J. Comp. Physiol. Psychol. 93 1979 74 104 (Pubitemid 9140564)
6. W.W. Beatty, N. Butters, and D.S. Janowsky Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia Behav. Neural Biol. 45 1986 196 211 (Pubitemid 16164035)
7. J. Ben-Barak, and Y. Dudai Scopolamine induces an increase in muscarinic receptor level in rat hippocampus Brain Res. 193 1980 309 313 (Pubitemid 10120991)
8. D.M. Bowen, C.B. Smith, P. White, and A.N. Davison Neurotransmitter- related enzymes and indices of hypoxia in senile dementia and other abiotrophies Brain 99 1976 459 496
9. L. Buizza, G. Cenini, C. Lanni, G. Ferrari-Toninelli, C. Prandelli, S. Govoni, E. Buoso, M. Racchi, M. Barcikowska, M. Styczynska, A. Szybinska, D.A. Butterfield, M. Memo, and D. Uberti Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease PLoS One 7 2012 e29789
10. J.M. Candy, R.H. Perry, E.K. Perry, D. Irving, G. Blessed, A.F. Fairbairn, and B.E. Tomlinson Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases J. Neurol. Sci. 59 1983 277 289 (Pubitemid 13113569)
11. B.R. Carlson, K.E. Lloyd, A. Kruszewski, I.H. Kim, R.M. Rodriguiz, C. Heindel, M. Faytell, S.M. Dudek, W.C. Wetsel, and S.H. Soderling WRP/srGAP3 facilitates the initiation of spine development by an inverse F-BAR domain, and its loss impairs long-term memory J. Neurosci. 31 2011 2447 2460
12. A. Castegna, M. Aksenov, M. Aksenova, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, and D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 Free Radic. Biol. Med. 33 2002 562 571 (Pubitemid 34874977)
13. D.Y. Chen, S.A. Stern, A. Garcia-Osta, B. Saunier-Rebori, G. Pollonini, D. Bambah-Mukku, R.D. Blitzer, and C.M. Alberini A critical role for IGF-II in memory consolidation and enhancement Nature 469 2011 491 497
14. D. Collerton Cholinergic function and intellectual decline in Alzheimer's disease Neuroscience 19 1986 1 28 (Pubitemid 16053626)
15. R.G. Cutler, J. Kelly, K. Storie, W.A. Pedersen, A. Tammara, K. Hatanpaa, J.C. Troncoso, and M.P. Mattson Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 101 2004 2070 2075 (Pubitemid 38229016)
16. U. Ebert, and W. Kirch Scopolamine model of dementia: electroencephalogram findings and cognitive performance Eur. J. Clin. Investig. 28 1998 944 949 (Pubitemid 28521587)
17. D.W. Ellison, M.F. Beal, and J.B. Martin Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease Brain Res. 417 1987 389 392 (Pubitemid 17158872)
18. D.A. El-Sherbiny, A.E. Khalifa, A.S. Attia, and E. Eldenshary Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine Pharmacol. Biochem. Behav. 76 2003 525 533 (Pubitemid 37487909)
19. Y. Fan, J. Hu, J. Li, Z. Yang, X. Xin, J. Wang, J. Ding, and M. Geng Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms Neurosci. Lett. 374 2005 222 226 (Pubitemid 40128300)
20. M.B. Feany, and D.W. Dickson Neurodegenerative disorders with extensive tau pathology: a comparative study and review Ann. Neurol. 40 1996 139 148 (Pubitemid 26274548)
21. A. Fischer, F. Sananbenesi, P.T. Pang, B. Lu, and L.H. Tsai Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory Neuron 48 2005 825 838 (Pubitemid 41759432)
22. J.F. Flood, and A. Cherkin Scopolamine effects on memory retention in mice: a model of dementia? Behav. Neural Biol. 45 1986 169 184 (Pubitemid 16164033)
23. M.N. Gadaleta, V. Petruzzella, M. Renis, F. Fracasso, and P. Cantatore Reduced transcription of mitochondrial DNA in the senescent rat. Tissue dependence and effect of L-carnitine Eur. J. Biochem. 187 1990 501 506 (Pubitemid 20074912)
24. A. Giancaterini, A. De Gaetano, G. Mingrone, D. Gniuli, E. Liverani, E. Capristo, and A.V. Greco Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients Metabol. Clin. Exp. 49 2000 704 708 (Pubitemid 30354575)
25. R.B. Gibbs Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition Horm. Behav. 36 1999 222 233 (Pubitemid 30023039)
26. R.B. Gibbs, and P. Aggarwal Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline Horm. Behav. 34 1998 98 111 (Pubitemid 28541752)
27. T.M. Hagen, R.T. Ingersoll, C.M. Wehr, J. Lykkesfeldt, V. Vinarsky, J.C. Bartholomew, M.H. Song, and B.N. Ames Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity Proc. Natl. Acad. Sci. U. S. A. 95 1998 9562 9566 (Pubitemid 28506271)
28. I. Hajimohammadreza, and M. Brammer Brain membrane fluidity and lipid peroxidation in Alzheimer's disease Neurosci. Lett. 112 1990 333 337
29. E.D. Hall, and J.M. Braughler Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation Free Radic. Biol. Med. 6 1989 303 313 (Pubitemid 19076496)
30. B. Halliwell, J.M. Gutteridge, and C.E. Cross Free radicals, antioxidants, and human disease: where are we now? J. Lab. Clin. Med. 119 1992 598 620
31. W.G. Honer, I. Prohovnik, G. Smith, and L.R. Lucas Scopolamine reduces frontal cortex perfusion J. Cereb. Blood Flow Metab. 8 1988 635 641
32. S. Hoyer Abnormalities of glucose metabolism in Alzheimer's disease Ann. N. Y. Acad. Sci. 640 1991 53 58
33. S. Hoyer Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases Mol. Chem. Neuropathol. 16 1992 207 224
34. L. Janiri, M. Falcone, A. Persico, and E. Tempesta Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo J. Neural Transm. Gen. Sect. 86 1991 135 146
35. E.J. Jeong, K.Y. Lee, S.H. Kim, S.H. Sung, and Y.C. Kim Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice Eur. J. Pharmacol. 588 2008 78 84
36. S. Kar, D. Seto, S. Dore, U. Hanisch, and R. Quirion Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation Proc. Natl. Acad. Sci. U. S. A. 94 1997 14054 14059 (Pubitemid 28009708)
37. S.J. Kish Brain energy metabolizing enzymes in Alzheimer's disease: alpha-ketoglutarate dehydrogenase complex and cytochrome oxidase Ann. N. Y. Acad. Sci. 826 1997 218 228 (Pubitemid 27478043)
38. M.D. Kopelman, and T.H. Corn Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome Brain 111 Pt 5 1988 1079 1110
39. S.H. Kwon, H.K. Lee, J.A. Kim, S.I. Hong, H.C. Kim, T.H. Jo, Y.I. Park, C.K. Lee, Y.B. Kim, S.Y. Lee, and C.G. Jang Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice Eur. J. Pharmacol. 649 2010 210 217
40. M.P. McDonald, E.E. Dahl, J.B. Overmier, P. Mantyh, and J. Cleary Effects of an exogenous beta-amyloid peptide on retention for spatial learning Behav. Neural Biol. 62 1994 60 67
41. P. Mecocci, U. MacGarvey, and M.F. Beal Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease Ann. Neurol. 36 1994 747 751 (Pubitemid 24337634)
42. P. Mecocci, U. MacGarvey, A.E. Kaufman, D. Koontz, J.M. Shoffner, D.C. Wallace, and M.F. Beal Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain Ann. Neurol. 34 1993 609 616 (Pubitemid 23289414)
43. O. Miatto, R.G. Gonzalez, F. Buonanno, and J.H. Growdon In vitro 31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer's disease Can. J. Neurol. Sci. 13 1986 535 539 (Pubitemid 17212717)
44. S.A. Montgomery, L.J. Thal, and R. Amrein Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease Int. Clin. Psychopharmacol. 18 2003 61 71 (Pubitemid 36343974)
45. R.G. Morris, E. Anderson, G.S. Lynch, and M. Baudry Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 Nature 319 1986 774 776 (Pubitemid 16145031)
46. R.M. Nitsch, J.K. Blusztajn, A.G. Pittas, B.E. Slack, J.H. Growdon, and R.J. Wurtman Evidence for a membrane defect in Alzheimer disease brain Proc. Natl. Acad. Sci. U. S. A. 89 1992 1671 1675
47. Y. Ohyagi, H. Asahara, D.H. Chui, Y. Tsuruta, N. Sakae, K. Miyoshi, T. Yamada, H. Kikuchi, T. Taniwaki, H. Murai, K. Ikezoe, H. Furuya, T. Kawarabayashi, M. Shoji, F. Checler, T. Iwaki, T. Makifuchi, K. Takeda, J. Kira, and T. Tabira Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease Faseb J. 19 2005 255 257 (Pubitemid 40189273)
48. A.M. Palmer, and M.A. Burns Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease Brain Res. 645 1994 338 342
49. R.C. Pearson, M.M. Esiri, R.W. Hiorns, G.K. Wilcock, and T.P. Powell Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 82 1985 4531 4534 (Pubitemid 15233154)
50. J.W. Pettegrew, W.E. Klunk, K. Panchalingam, J.N. Kanfer, and R.J. McClure Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease Neurobiol. Aging 16 1995 1 4
51. J.W. Pettegrew, S.J. Kopp, N.J. Minshew, T. Glonek, J.M. Feliksik, J.P. Tow, and M.M. Cohen 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations J. Neuropathol. Exp. Neurol. 46 1987 419 430 (Pubitemid 17105150)
52. J.W. Pettegrew, K. Panchalingam, W.E. Klunk, R.J. McClure, and L.R. Muenz Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study Neurobiol. Aging 15 1994 117 132 (Pubitemid 24075020)
53. Z. Quan, X. Han, Z. Ye, Y. Chenzhong, and C. Wenjun Influence of novel nano-mesoporous bioactive glass on the regulation of IGF-II gene expression in osteoblasts Cell Biochem. Biophys. 62 2012 119 123
54. T. Sakurai, T. Kato, K. Mori, E. Takano, S. Watabe, and T. Nabeshima Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions: an in vivo microdialysis study Neurosci. Lett. 246 1998 69 72 (Pubitemid 28207078)
55. R. Schliebs, and T. Arendt The significance of the cholinergic system in the brain during aging and in Alzheimer's disease J. Neural Transm. 113 2006 1625 1644 (Pubitemid 44657659)
56. M.K. Shigenaga, T.M. Hagen, and B.N. Ames Oxidative damage and mitochondrial decay in aging Proc. Natl. Acad. Sci. U. S. A. 91 1994 10771 10778 (Pubitemid 24349567)
57. C.D. Smith, J.M. Carney, P.E. Starke-Reed, C.N. Oliver, E.R. Stadtman, R.A. Floyd, and W.R. Markesbery Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 88 1991 10540 10543 (Pubitemid 21915871)
58. I.L. Soneru, T. Khan, Z. Orfalian, and C. Abraira Acetyl-L-carnitine effects on nerve conduction and glycemic regulation in experimental diabetes Endocr. Res. 23 1997 27 36 (Pubitemid 27272708)
59. A. Spagnoli, U. Lucca, G. Menasce, L. Bandera, G. Cizza, G. Forloni, M. Tettamanti, L. Frattura, P. Tiraboschi, M. Comelli, and A. Et Long-term acetyl-L-carnitine treatment in Alzheimer's disease Neurology 41 1991 1726 1732
60. E. Steen, B.M. Terry, E.J. Rivera, J.L. Cannon, T.R. Neely, R. Tavares, X.J. Xu, J.R. Wands, and S.M. de la Monte Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J. Alzheimers Dis. 7 2005 63 80 (Pubitemid 40387185)
61. A. Stephan, S. Laroche, and S. Davis Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits J. Neurosci. 21 2001 5703 5714 (Pubitemid 32692169)
62. K.V. Subbarao, J.S. Richardson, and L.C. Ang Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro J. Neurochem. 55 1990 342 345
63. T. Sunderland, P. Tariot, D.L. Murphy, H. Weingartner, E.A. Mueller, and R.M. Cohen Scopolamine challenges in Alzheimer's disease Psychopharmacology (Berl) 87 1985 247 249 (Pubitemid 16253356)
64. W.J. Tyler, and L. Pozzo-Miller Miniature synaptic transmission and BDNF modulate dendritic spine growth and form in rat CA1 neurones J. Physiol. 553 2003 497 509 (Pubitemid 37527549)
65. X. Wang, Z.H. Wang, Y.Y. Wu, H. Tang, L. Tan, X. Wang, X.Y. Gao, Y.S. Xiong, D. Liu, J.Z. Wang, and L.Q. Zhu Melatonin attenuates scopolamine-induced memory/synaptic disorder by rescuing EPACs/miR-124/Egr1 pathway Mol. Neurobiol. 47 2013 373 381
66. H.H. Wu, J.A. Thomas, and J. Momand p53 protein oxidation in cultured cells in response to pyrrolidine dithiocarbamate: a novel method for relating the amount of p53 oxidation in vivo to the regulation of p53-responsive genes Biochem. J. 351 2000 87 93
67. Y.Y. Yin, H. Liu, X.B. Cong, Z. Liu, Q. Wang, J.Z. Wang, and L.Q. Zhu Acetyl-L-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats J. Alzheimers Dis. 19 2010 735 746
68. L. Zhang, F. Kashanchi, Q. Zhan, S. Zhan, J.N. Brady, A.J. Fornace, P. Seth, and L.J. Helman Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis Cancer Res. 56 1996 1367 1373 (Pubitemid 26080981)
69. L. Zhang, Q. Zhan, S. Zhan, F. Kashanchi, A.J. Fornace, P. Seth, and L.J. Helman p53 regulates human insulin-like growth factor II gene expression through active P4 promoter in rhabdomyosarcoma cells Dna Cell Biol. 17 1998 125 131 (Pubitemid 28113861)
70. P. Zhou, Z. Chen, N. Zhao, D. Liu, Z.Y. Guo, L. Tan, J. Hu, Q. Wang, J.Z. Wang, and L.Q. Zhu Acetyl-L-carnitine attenuates homocysteine-induced Alzheimer-like histopathological and behavioral abnormalities Rejuv. Res. 14 2011 669 679